Your browser doesn't support javascript.
loading
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
Mitamura, T; Pradeep, S; McGuire, M; Wu, S Y; Ma, S; Hatakeyama, H; Lyons, Y A; Hisamatsu, T; Noh, K; Villar-Prados, A; Chen, X; Ivan, C; Rodriguez-Aguayo, C; Hu, W; Lopez-Berestein, G; Coleman, R L; Sood, A K.
Affiliation
  • Mitamura T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pradeep S; Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • McGuire M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu SY; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Ma S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hatakeyama H; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lyons YA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hisamatsu T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Noh K; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Villar-Prados A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen X; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Gene Therapy Research Unit, Korea Research Institute of Bioscience and Biotechnology, Dajeon, Republic of Korea.
  • Rodriguez-Aguayo C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Coleman RL; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sood AK; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 37(6): 722-731, 2018 02 08.
Article in En | MEDLINE | ID: mdl-29059175
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Peritoneal Neoplasms / Drug Resistance, Neoplasm / Vascular Endothelial Growth Factor A / Fallopian Tube Neoplasms / Bevacizumab / Carcinoma, Ovarian Epithelial / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Oncogene Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Peritoneal Neoplasms / Drug Resistance, Neoplasm / Vascular Endothelial Growth Factor A / Fallopian Tube Neoplasms / Bevacizumab / Carcinoma, Ovarian Epithelial / Neoplasm Proteins Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Oncogene Year: 2018 Document type: Article